Targeted estrogen/progestogen replacement therapy for osteoporosis: calculation of health care cost savings
- 1 July 1992
- journal article
- Published by Springer Nature in Osteoporosis International
- Vol. 2 (4) , 195-200
- https://doi.org/10.1007/bf01623926
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Baseline Measurement of Bone Mass Predicts Fracture in White WomenAnnals of Internal Medicine, 1989
- Predicting fractures in women by using forearm bone densitometryCalcified Tissue International, 1989
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.BMJ, 1989
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.BMJ, 1987
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- Race and sex differences in hip fracture incidence.American Journal of Public Health, 1984
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control StudyThe Lancet, 1979
- Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal WomenAnnals of Internal Medicine, 1977